Detalles de la búsqueda
1.
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 203(2): 339-349, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878148
2.
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
Breast Cancer Res Treat
; 198(2): 239-251, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635428
3.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 192(2): 331-342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025003
4.
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Breast Cancer Res Treat
; 188(2): 571-581, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743103
5.
Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study.
Cancer
; 126(24): 5283-5292, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002193
6.
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Breast Cancer Res Treat
; 181(1): 77-86, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236826
7.
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Int J Cancer
; 145(1): 274-283, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30588619
8.
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.
Breast Cancer Res Treat
; 162(2): 353-364, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28132393
9.
Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study.
Eur J Obstet Gynecol Reprod Biol
; 293: 27-31, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100938
10.
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
EClinicalMedicine
; 58: 101901, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992863
11.
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
JNCI Cancer Spectr
; 7(6)2023 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991939
12.
The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study.
Cancers (Basel)
; 12(8)2020 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32731426
13.
Unraveling the Heterogeneity of Sarcoma Survivors' Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study.
Cancers (Basel)
; 12(11)2020 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33105807
14.
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers.
Eur J Cancer
; 81: 74-80, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28618304
15.
The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.
Oncotarget
; 8(7): 11372-11379, 2017 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28076330
16.
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.
J Natl Cancer Inst
; 109(12)2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29546343
Resultados
1 -
16
de 16
1
Próxima >
>>